@article{ARH3990,
author = {Yi Bai and Haitao Zhao},
title = {A novel indication to treat distinct types of tumors with PD-1 blockade based on mismatch-repair deficiency},
journal = {Annals of Research Hospitals},
volume = {2},
number = {02},
year = {2018},
keywords = {},
abstract = {Le et al. conducted a prospective study (Clinical-Trials.gov number, NCT01876511) to evaluate effects of programmed death-1 (PD-1) blockade (pembrolizumab) therapy in different kinds of tumors with mismatch repair-deficient (1).},
issn = {2523-0743}, url = {https://arh.amegroups.org/article/view/3990}
}